{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:13:47Z","timestamp":1790702027143,"version":"4.1.0"},"reference-count":67,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003965","name":"Migraine Research Foundation","doi-asserted-by":"publisher","award":["2019 Migraine Research Foundation Impact Award"],"award-info":[{"award-number":["2019 Migraine Research Foundation Impact Award"]}],"id":[{"id":"10.13039\/100003965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The endocannabinoid system exerts an important role in pain processing and modulation. Modulation of the system with hydrolase inhibitors of anandamide (AEA) or 2-arachidonyl glycerol (2-AG) has proved effective in reducing migraine-like features in animal models of migraine. Here, we investigated the effect of dual inhibition of the AEA and 2-AG catabolic pathways in the nitroglycerin-based animal model of migraine. The dual inhibitor JZL195 was administered to rats 2 h after nitroglycerin or vehicle injection. Rats were then exposed to the open field test and the orofacial formalin test. At the end of the tests, they were sacrificed to evaluate calcitonin gene-related peptide (CGRP) serum levels and gene expression of CGRP and cytokines in the cervical spinal cord and the trigeminal ganglion. The dual inhibitor significantly reduced the nitroglycerin-induced trigeminal hyperalgesia and pain-associated behavior, possibly via cannabinoid 1 receptors-mediated action, but it did not change the hypomotility and the anxiety behaviors induced by nitroglycerin. The decreased hyperalgesia was associated with a reduction in CGRP and cytokine gene expression levels in central and peripheral structures and reduced CGRP serum levels. These data suggest an antinociceptive synergy of the endocannabinoid action in peripheral and central sites, confirming that this system participates in reduction of cephalic pain signals.<\/jats:p>","DOI":"10.3390\/cells10102543","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T01:59:47Z","timestamp":1632707987000},"page":"2543","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine"],"prefix":"10.3390","volume":"10","author":[{"given":"Rosaria","family":"Greco","sequence":"first","affiliation":[{"name":"Unit of Translational Neurovascular Research, IRCCS Mondino Foundation, via Mondino 2, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-7773","authenticated-orcid":false,"given":"Chiara","family":"Demartini","sequence":"additional","affiliation":[{"name":"Unit of Translational Neurovascular Research, IRCCS Mondino Foundation, via Mondino 2, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Francavilla","sequence":"additional","affiliation":[{"name":"Unit of Translational Neurovascular Research, IRCCS Mondino Foundation, via Mondino 2, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Zanaboni","sequence":"additional","affiliation":[{"name":"Unit of Translational Neurovascular Research, IRCCS Mondino Foundation, via Mondino 2, 27100 Pavia, Italy"},{"name":"Department of Brain and Behavioral Sciences, University of Pavia, via Bassi 21, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[{"name":"Unit of Translational Neurovascular Research, IRCCS Mondino Foundation, via Mondino 2, 27100 Pavia, Italy"},{"name":"Department of Brain and Behavioral Sciences, University of Pavia, via Bassi 21, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The Endocannabinoid System and Pain","volume":"8","author":"Guindon","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/can.2017.0017","article-title":"Cannabis and pain: A clinical review","volume":"2","author":"Hill","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","article-title":"Cannabinoid receptors and pain","volume":"63","author":"Pertwee","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjp.0706990","article-title":"The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors","volume":"150","author":"Guindon","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.111.180257","article-title":"Mechanistic and pharmacological characterization of PF-04457845: A highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain","volume":"338","author":"Ahn","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2013.12.018","article-title":"Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine inflammatory pain model","volume":"81","author":"Anderson","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/nmo.12563","article-title":"The effect of FAAH, MAGL, and Dual FAAH\/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents","volume":"27","author":"Sakin","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-662-46450-2_7","article-title":"The role of the endocannabinoid system in pain","volume":"227","author":"Woodhams","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","article-title":"Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities","volume":"367","author":"Pertwee","year":"2012","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/bph.13337","article-title":"Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine neuropathic pain model","volume":"173","author":"Mitchell","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1111\/bph.13970","article-title":"Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats","volume":"174","author":"Zubrzycki","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroscience.2009.03.019","article-title":"Neurobiology of migraine","volume":"161","author":"Goadsby","year":"2009","journal-title":"Neuroscience"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11916-009-0040-y","article-title":"Migraine pain, meningeal inflammation, and mast cells","volume":"13","author":"Levy","year":"2009","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: Multiple processes, complex pathophysiology","volume":"35","author":"Burstein","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14869","DOI":"10.1523\/JNEUROSCI.0943-13.2013","article-title":"Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and \u201ctriptan\u201d receptors: Implications in migraine","volume":"33","author":"Akerman","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/0333102415613766","article-title":"The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat","volume":"36","author":"Tar","year":"2016","journal-title":"Cephalalgia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1468-2982.2005.01031.x","article-title":"Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs","volume":"26","author":"Cupini","year":"2006","journal-title":"Cephalalgia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.nbd.2008.01.003","article-title":"Degradation of endocannabinoids in chronic migraine and medication overuse headache","volume":"30","author":"Cupini","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1526-4610.2012.02170.x","article-title":"Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment","volume":"52","author":"Perrotta","year":"2012","journal-title":"Headache"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/sj.npp.1301246","article-title":"Endocannabinoids in chronic migraine: CSF findings suggest a system failure","volume":"32","author":"Sarchielli","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fnins.2018.00172","article-title":"Endocannabinoid System and Migraine Pain: An Update","volume":"12","author":"Greco","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0333102420949201","article-title":"Peripheral changes of endocannabinoid system components in episodic and chronic migraine patients: A pilot study","volume":"41","author":"Greco","year":"2021","journal-title":"Cephalalgia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.euroneuro.2015.04.001","article-title":"Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice","volume":"25","author":"Nozaki","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0333102414566862","article-title":"Effects of peripheral FAAH blockade on NTG-induced hyperalgesia\u2014Evaluation of URB937 in an animal model of migraine","volume":"35","author":"Greco","year":"2015","journal-title":"Cephalalgia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/0333102417727537","article-title":"Inhibition of monoacylglycerol lipase: Another signalling pathway for potential therapeutic targets in migraine?","volume":"38","author":"Greco","year":"2018","journal-title":"Cephalalgia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104624","DOI":"10.1016\/j.nbd.2019.104624","article-title":"FAAH inhibition as a preventive treatment for migraine: A pre-clinical study","volume":"134","author":"Greco","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"105157","DOI":"10.1016\/j.nbd.2020.105157","article-title":"Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine","volume":"147","author":"Greco","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo","volume":"106","author":"Long","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.euroneuro.2015.04.005","article-title":"Distinct roles of the endocannabinoid\u2019s anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats","volume":"25","author":"Manduca","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3\u2032-carbamoyl-biphenyl-3-yl ester (URB597): Effects on anandamide and oleoylethanolamide deactivation","volume":"313","author":"Fegley","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pbb.2014.05.022","article-title":"The dual FAAH\/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184","volume":"124","author":"Seillier","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"116670","DOI":"10.1016\/j.lfs.2019.116670","article-title":"Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study","volume":"232","author":"Vosough","year":"2019","journal-title":"Life Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fncel.2018.00294","article-title":"The Effects of Chronic Stress on Migraine Relevant Phenotypes in Male Mice","volume":"12","author":"Kaufmann","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s10194-019-0963-6","article-title":"Behavioral and cognitive animal models in headache research","volume":"20","author":"Vuralli","year":"2019","journal-title":"J. Headache Pain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neubiorev.2003.12.003","article-title":"The orofacial formalin test","volume":"28","author":"Raboisson","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(03)00333-6","article-title":"The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat","volume":"120","author":"Price","year":"2003","journal-title":"Neuroscience"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1468-2982.2007.01312.x","article-title":"Cannabinoid and vanilloid effects of R(+)-methanandamide in the hemisected meningeal preparation","volume":"27","author":"Fischer","year":"2007","journal-title":"Cephalalgia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/sj.bjp.0705896","article-title":"Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors","volume":"142","author":"Akerman","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10194-010-0274-4","article-title":"Effects of anandamide in migraine: Data from an animal model","volume":"12","author":"Greco","year":"2011","journal-title":"J. Headache Pain"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1129-2377-15-14","article-title":"Activation of CB2 receptors as a potential therapeutic target for migraine: Evaluation in an animal model","volume":"15","author":"Greco","year":"2014","journal-title":"J. Headache Pain"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kilinc, E., Ankarali, S., Torun, I.E., and Dagistan, Y. (2020). Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine. Eur. J. Neurosci.","DOI":"10.1111\/ejn.14897"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1468-2982.2009.01924.x","article-title":"Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat","volume":"30","author":"Greco","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-013-3282-7","article-title":"Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system","volume":"231","author":"Limebeer","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.npep.2011.03.005","article-title":"Inhibitory CB1 and activating\/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin","volume":"45","author":"Engel","year":"2011","journal-title":"Neuropeptides"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/glia.20084","article-title":"Cannabinoid signaling in glial cells","volume":"48","author":"Stella","year":"2004","journal-title":"Glia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.bjp.0706093","article-title":"The expanding field of cannabimimetic and related lipid mediators","volume":"144","author":"Bradshaw","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1111\/bph.15208","article-title":"Cannabinoid control of neurogenic inflammation","volume":"177","author":"McKenna","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/glia.20229","article-title":"Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures","volume":"52","author":"Guaza","year":"2005","journal-title":"Glia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17558","DOI":"10.1073\/pnas.1314017110","article-title":"Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6","volume":"110","author":"Alhouayek","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/brain\/124.12.2490","article-title":"Delayed inflammation in rat meninges: Implications for migraine pathophysiology","volume":"124","author":"Reuter","year":"2001","journal-title":"Brain"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.bjp.0707425","article-title":"The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation","volume":"152","author":"Comelli","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1476-5381.2012.02237.x","article-title":"The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: Differential mechanisms of action","volume":"169","author":"Kerr","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.2174\/1381612820666140130202911","article-title":"Brain innate immunity in the regulation of neuroinflammation: Therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system","volume":"20","author":"Mecha","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0301-0082(94)90023-X","article-title":"Nitric oxide: A radical neurotransmitter in the central nervous system","volume":"42","author":"Vincent","year":"1994","journal-title":"Prog. Neurobiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"109276","DOI":"10.1016\/j.biopha.2019.109276","article-title":"Effect of Paeonia lactiflora, a traditional Chinese herb, on migraines based on clinical application and animal behavior analyses","volume":"118","author":"Liao","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e05654","DOI":"10.1016\/j.heliyon.2020.e05654","article-title":"Nitric oxide role in anxiety-like behavior, memory and cognitive impairments in animal model of chronic migraine","volume":"6","author":"Taheri","year":"2020","journal-title":"Heliyon"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s10194-016-0624-y","article-title":"Clinically relevant behavioral endpoints in a recurrent nitroglycerin migraine model in rats","volume":"17","author":"Sufka","year":"2016","journal-title":"J. Headache Pain"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/cn200130s","article-title":"Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice","volume":"3","author":"Wise","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbr.2013.05.027","article-title":"Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray","volume":"252","author":"Gobira","year":"2013","journal-title":"Behav. Brain Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2010.12.002","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay","volume":"98","author":"Kinsey","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.phrs.2011.04.010","article-title":"Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats","volume":"64","author":"Sciolino","year":"2011","journal-title":"Pharmacol. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.chembiol.2009.02.013","article-title":"Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain","volume":"16","author":"Ahn","year":"2009","journal-title":"Chem. Biol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/10\/2543\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:05:19Z","timestamp":1760166319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/10\/2543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":67,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["cells10102543"],"URL":"https:\/\/doi.org\/10.3390\/cells10102543","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,26]]}}}